???global.info.a_carregar???
Ana Maria Rodrigues Pereira is a researcher at the Center for Neuroscience and Cell Biology (CNC-UC), in the “Gene and Stem Cell Therapy for the Brain” group. She holds a Bachelor's degree in Biotechnology from Escola Superior Agrária de Coimbra (2021) and a Master's degree in Pharmaceutical Biotechnology from the Faculty of Pharmacy, University of Coimbra (2024). Her master's thesis, entitled "Engineering RNA-Targeting CRISPR/Cas13 for Allele-Specific ATXN3 Knockdown as a Novel Treatment for Spinocerebellar Ataxia Type 3", focused on the engineering and evaluation of CRISPR/Cas13d sequences for allele-specific silencing of the mutant ATXN3 gene as a potential therapeutic approach for Spinocerebellar Ataxia Type 3. Her technical expertise includes the design and evaluation of gene editing sequences, molecular cloning, western blot, qPCR, immunohistochemistry, flow cytometry, cell culture, and viral production. She has disseminated her work through multiple posters and oral communications at national and international meetings, including the Portuguese Society of Human Genetics, the Portuguese Society of Pharmacology, and the European Society of Gene and Cell Therapy Congress. Her research focuses on the development of gene-based therapeutic approaches for neurodegenerative disorders, with particular emphasis on Spinocerebellar Ataxia Type 3 (MJD/SCA3), exploring RNA-targeting CRISPR technologies and viral delivery systems for potential therapeutic applications.
Identification

Personal identification

Full name
Ana Maria Rodrigues Pereira

Citation names

  • Pereira, Ana Maria

Author identifiers

Ciência ID
9419-7964-7D1A
ORCID iD
0009-0000-2644-322X

Email addresses

  • anampereira2000@gmail.com (Professional)
  • anapereira@cnc.uc.pt (Professional)

Knowledge fields

  • Medical and Health Sciences - Medical Biotechnology - Health-Related Biotechnology
  • Medical and Health Sciences - Medical Biotechnology - Gene-based Diagnostics and Therapeutic Interventions
  • Medical and Health Sciences - Medical Biotechnology - Technologies Involving the Manipulation of Cells, Tissues, Organs or the Whole Organism

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Intermediate (B1) Upper intermediate (B2) Upper intermediate (B2) Intermediate (B1)
Education
Degree Classification
2022/10 - 2024/10
Concluded
Pharmaceutical Biotechnology (Master's Degree)
Universidade de Coimbra Faculdade de Farmácia, Portugal
"Engineering RNA-Targeting CRISPR/Cas13 for Allele-Specific ATXN3 Knockdown as a Novel Treatment for Spinocerebellar Ataxia Type 3" (THESIS/DISSERTATION)
18
2018/09 - 2021/12
Concluded
Biotechnology (Licenciate Degree)
Instituto Politécnico de Coimbra Escola Superior Agrária de Coimbra, Portugal
"Implementation of a method for amino acid analysis by LC-ESI-MS" (THESIS/DISSERTATION)
14
Affiliation

Science

Category
Host institution
Employer
2025/02 - Current Researcher (Research) Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal

Others

Category
Host institution
Employer
2023/09 - 2024/10 Master Student - Gene and Stem Cell Therapies for the Brain Group Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Projects

Grant

Designation Funders
2026/04/01 - 2027/03/31 Non-Cell Autonomous Effects in SCA3: Elucidating Astrocyte-Induced Neuronal Dysfunction in a Human Patient-Derived Model
1564453
Research Fellow
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
National Ataxia Foundation
Ongoing
2024/03/01 - 2025/02/28 Engineering RNA-Targeting CRISPR/Cas13 for the Treatment of Spinocerebellar Ataxia Type 3
25124
Research Fellow
Universidade de Coimbra, Portugal
AFM-Téléthon
Concluded

Contract

Designation Funders
2024/01 - 2029/12 GeneT - Gene Therapy Center of Excellence Portugal
101059981
Research Fellow
Universidade de Coimbra, Portugal

The University of Sheffield, United Kingdom

Itä-Suomen yliopisto, Finland
European Commission
Ongoing
2023/01 - 2026/06 CInTech - Technological Hub for Innovation, Translation and Industrialization of Complex Injectable Drugs
C644865576-00000005
Research Fellow
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal

Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal

Universidade de Coimbra, Portugal
PRR - Plano de Recuperação e Resiliência
Ongoing
Outputs

Publications

Conference poster
  1. Pereira, Ana Maria; Pires, Mariana; Tomás, Inês; Silva, Ana Carolina; Almeida, Rita B.; Fernandes, Ana Rita; Pena, Frederico; et al. "Engineering RNA-Targeting CRISPR/Cas13 for Allele-Specific ATXN3 Knockdown for Treatment of Spinocerebellar Ataxia Type 3". Paper presented in 29th Annual Meeting of the Portuguese Society of Human Genetics, 2025.
  2. Pereira, Ana Maria; Pires, Mariana; Silva, Ana Carolina; Almeida, Rita B.; Fernandes, Ana Rita; Pena, Frederico; Tomás, Inês; et al. "Engineering RNA-Targeting CRISPR/Cas13 Ribonucleases for Allele-Specific Knockdown of Mutant ATXN3 for Treatment of Spinocerebellar Ataxia Type 3". Paper presented in 32nd Annual Congress of the European Society of Gene and Cell Therapy, 2025.
  3. Pena, Frederico; Fernandes, Ana Rita; Miguel M. Lopes; Núñez, Jisette; Faro, Rosario; Pires, Mariana; Pereira, Ana Maria; et al. "Establishment of a Scalable Neuronal Reporter Model of Machado-Joseph Disease Based on Gene-Edited Patient Cells as a Platform for High-Throughput Drug Repurposing". Paper presented in 32nd Annual Congress of the European Society of Gene and Cell Therapy, 2025.
Thesis / Dissertation
  1. "Engineering RNA-Targeting CRISPR/Cas13 for Allele-Specific ATXN3 Knockdown as a Novel Treatment for Spinocerebellar Ataxia Type 3". Master, Universidade de Coimbra Faculdade de Farmácia, 2024. https://hdl.handle.net/10316/119218.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2026/02 Engineering RNA-Targeting CRISPR/Cas13 for Allele-Specific ATXN3 Knockdown for Treatment of Spinocerebellar Ataxia Type 3 56th Meeting of the Portuguese Society of Pharmacology
Faculty of Pharmacy, University of Coimbra

Event participation

Activity description
Type of event
Event name
Institution / Organization
2026/03/16 - 2026/03/22 International Brain Awareness Week is an initiative designed to raise awareness of the advances and benefits of neuroscience research International Brain Awareness Week
Sociedade Portuguesa de Neurociências, Portugal

Ciência Viva, Portugal
2026/02/27 - 2026/02/27 The Rare Disease Day Parade featured GeneT and CNC-UC. It consisted of engaging with shopkeepers and citizens, sharing information about rare diseases, their incidence and specificities, and raising awareness of the research they carry out at the University of Coimbra. Rare Diseases Day Street Parade
Universidade de Coimbra, Portugal
2025/11/24 - 2025/11/30 Science and Technology Week aims to connect the public with researchers, who will thus have the opportunity to get in touch with the scientific community and learn about some of the most recent research results in various scientific areas Science and Technology Week
Ciência Viva, Portugal
2025/09/26 - 2025/09/26 The European Researchers' Night (NEI) is a Scientific Communication event that occurs annually in several European cities. This events aims to promote awareness and involvement of the scientific population, bringing researchers and civil society together. European Researchers' Night - Coimbra
Universidade de Coimbra, Portugal
2024/09/27 - 2024/09/27 The European Researchers' Night (NEI) is a Scientific Communication event that occurs annually in several European cities. This events aims to promote awareness and involvement of the scientific population, bringing researchers and civil society together. European Researchers' Night - Coimbra
Universidade de Coimbra, Portugal
Distinctions

Award

2024 Merit Board for top 5% students 2023/2024
Universidade de Coimbra, Portugal

Title

2025 Poster Highlight
Sociedade Portuguesa de Genética Humana, Portugal